Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ACP-204 Alzheimer's Disease (Phase 2/3) Acadia Pharmaceuticals Other Neurotransmitters Small Molecule
AXS-05 Dextromethorphan/bupropion,
Auvelity
Alzheimer's Disease (Phase 2/3) Axsome Therapeutics, Inc. Other Neurotransmitters Combination, Small Molecule Major depressive disorder
Blarcamesine Anavex 2-73 Alzheimer's Disease (Phase 2/3), Parkinson's Disease Dementia (Phase 2), Parkinson's Disease (Phase 1) Anavex Life Science Corp. Other Small Molecule
Fosgonimeton ATH-1017,
NDX-1017
Alzheimer's Disease (Phase 2/3), Dementia with Lewy Bodies (Phase 2), Parkinson's Disease Dementia (Phase 2) Athira Pharma Other Small Molecule
Metformin Glucophage,
Glucophage XR
Alzheimer's Disease (Phase 2/3) Other Small Molecule Type 2 Diabetes
Vascepa Icosapent ethyl (IPE),
Ethyl eicosapentaenoic acid (E-EPA),
AMR101,
Miraxion
Alzheimer's Disease (Phase 2/3) Other Small Molecule Severe hypertriglyceridemia, and to lower risk of cardiovascular events in people with elevated triglycerides